房颤患者死亡风险预测模型研究进展
Advances in Mortality Risk Prediction Modeling for Atrial Fibrillation
DOI: 10.12677/acm.2026.1652098, PDF,   
作者: 雷 洲, 唐 正, 李欣悦, 汪劼宇, 张浩轩, 殷跃辉*:重庆医科大学附属第二医院心血管内科,重庆
关键词: 心房颤动死亡风险预测模型Atrial Fibrillation Mortality Risk Prediction Model
摘要: 心房颤动(atrial fibrillation, AF)是最常见的持续性心律失常,其患者的心血管死亡和全因死亡风险均显著升高,疾病负担日益加重。准确识别高危人群并进行死亡风险分层,对改善患者预后具有重要意义。目前国内外已建立了多种用于预测房颤患者死亡风险的临床模型,主要包括基于传统临床变量的风险评分(如CHA2DS2-VASc评分及其改良版本)、整合生物标志物的风险评分以及基于大型前瞻性真实世界研究的预测模型。近年来,随着机器学习与深度学习方法的不断进展,新型预测模型不断涌现。本文旨在介绍不同房颤死亡风险预测模型,以期为临床医护人员提供参考。
Abstract: Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, which is associated with a markedly elevated risk of cardiovascular and all-cause mortality, thereby imposing the growing burden of society. Precise risk stratification and early identification of high-risk individuals are critical for optimizing prognostic management and improving clinical outcomes. Currently, various predictive models for mortality risk in AF patients have been established, including risk scores based on clinical variables (such as the CHA2DS2-VASc score and its modified versions), risk scores incorporating biomarkers, and predictive models derived from large-scale prospective real-world studies. In recent years, with the advancement of machine learning and deep learning, novel predictive models have emerged. In this paper, we will introduce different risk prediction models for mortality in AF patients, providing a practical reference for clinical decision-making.
文章引用:雷洲, 唐正, 李欣悦, 汪劼宇, 张浩轩, 殷跃辉. 房颤患者死亡风险预测模型研究进展[J]. 临床医学进展, 2026, 16(5): 2856-2862. https://doi.org/10.12677/acm.2026.1652098

参考文献

[1] Cheng, S., He, J., Han, Y., Han, S., Li, P., Liao, H., et al. (2024) Global Burden of Atrial Fibrillation/Atrial Flutter and Its Attributable Risk Factors from 1990 to 2021. Europace, 26, euae195. [Google Scholar] [CrossRef] [PubMed]
[2] 中国心血管健康与疾病报告2022概要[J]. 中国循环杂志, 2023, 38(6): 583-612.
[3] Di Carlo, A., Bellino, L., Consoli, D., Mori, F., Zaninelli, A., Baldereschi, M., et al. (2019) Prevalence of Atrial Fibrillation in the Italian Elderly Population and Projections from 2020 to 2060 for Italy and the European Union: The FAI Project. EP Europace, 21, 1468-1475. [Google Scholar] [CrossRef] [PubMed]
[4] Weber, C., Hung, J., Hickling, S., Li, I., Murray, K. and Briffa, T. (2023) Emergent Readmission and Long-Term Mortality Risk after Incident Atrial Fibrillation Hospitalisation. Heart, 109, 380-387. [Google Scholar] [CrossRef] [PubMed]
[5] Gu, H., Yang, K., Zhao, X., Wang, Y., Liu, L., Li, Z., et al. (2024) Preexisting Heart Disease Spectrum and In‐Hospital Outcomes for Patients with Acute Ischemic Stroke. Stroke: Vascular and Interventional Neurology, 4, e001517. [Google Scholar] [CrossRef
[6] Reinhardt, S.W., Chouairi, F., Miller, P.E., Clark, K.A.A., Kay, B., Fuery, M., et al. (2021) National Trends in the Burden of Atrial Fibrillation during Hospital Admissions for Heart Failure. Journal of the American Heart Association, 10, e019412. [Google Scholar] [CrossRef] [PubMed]
[7] Odutayo, A., Wong, C.X., Hsiao, A.J., Hopewell, S., Altman, D.G. and Emdin, C.A. (2016) Atrial Fibrillation and Risks of Cardiovascular Disease, Renal Disease, and Death: Systematic Review and Meta-Analysis. BMJ, 354, i4482. [Google Scholar] [CrossRef] [PubMed]
[8] Buja, A., Rebba, V., Montecchio, L., Renzo, G., Baldo, V., Cocchio, S., et al. (2024) The Cost of Atrial Fibrillation: A Systematic Review. Value in Health, 27, 527-541. [Google Scholar] [CrossRef] [PubMed]
[9] Camm, A.J., Kirchhof, P., Lip, G.Y., Schotten, U., Savelieva, I., Ernst, S., et al. (2010) Guidelines for the Management of Atrial Fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). European Heart Journal, 31, 2369-2429.
[10] Apiyasawat, S., Tangcharoen, T., Wisaratapong, T., Yamwong, S., Wiboonpolprasert, S. and Sritara, P. (2015) CHA2DS2-VASc Scores Predict Mortality after Hospitalization for Atrial Fibrillation. International Journal of Cardiology, 185, 293-296. [Google Scholar] [CrossRef] [PubMed]
[11] Hijazi, Z., Oldgren, J., Lindbäck, J., Alexander, J.H., Connolly, S.J., Eikelboom, J.W., et al. (2018) A Biomarker-Based Risk Score to Predict Death in Patients with Atrial Fibrillation: The ABC (Age, Biomarkers, Clinical History) Death Risk Score. European Heart Journal, 39, 477-485. [Google Scholar] [CrossRef] [PubMed]
[12] Wang, B., Jin, F., Cao, H., Li, Q. and Zhang, P. (2024) Development of a Risk Score for Predicting One-Year Mortality in Patients with Atrial Fibrillation Using XGBoost-Assisted Feature Selection. Polish Heart Journal, 82, 941-948. [Google Scholar] [CrossRef] [PubMed]
[13] Lip, G.Y.H., Nieuwlaat, R., Pisters, R., Lane, D.A. and Crijns, H.J.G.M. (2010) Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach: The Euro Heart Survey on Atrial Fibrillation. Chest, 137, 263-272. [Google Scholar] [CrossRef] [PubMed]
[14] Proietti, M., Farcomeni, A., Romiti, G.F., Di Rocco, A., Placentino, F., Diemberger, I., et al. (2020) Association between Clinical Risk Scores and Mortality in Atrial Fibrillation: Systematic Review and Network Meta-Regression of 669,000 Patients. European Journal of Preventive Cardiology, 27, 633-644. [Google Scholar] [CrossRef] [PubMed]
[15] Wang, H., Li, K., Li, J., Lin, K., Shi, Y., Wang, H., et al. (2019) Moderate Chronic Kidney Disease and Left Atrial Enlargement Independently Predict Thromboembolic Events and Mortality in Elderly Patients with Atrial Fibrillation: A Retrospective Single-Center Study. Journal of International Medical Research, 47, 4312-4323. [Google Scholar] [CrossRef] [PubMed]
[16] Fu, S., Zhou, S., Luo, L. and Ye, P. (2017) R2(GFR)CHADS2 and R2(GFR)CHA2DS2VASC Schemes Improved the Performance of CHADS2 and CHA2DS2VASc Scores in Death Risk Stratification of Chinese Older Patients with Atrial Fibrillation. Clinical Interventions in Aging, 12, 1233-1238. [Google Scholar] [CrossRef] [PubMed]
[17] Niederdöckl, J., Simon, A., Schnaubelt, S., Schuetz, N., Laggner, R., Sulzgruber, P., et al. (2019) Cardiac Biomarkers Predict Mortality in Emergency Patients Presenting with Atrial Fibrillation. Heart, 105, 482-488. [Google Scholar] [CrossRef] [PubMed]
[18] Nopp, S., Königsbrügge, O., Kraemmer, D., Pabinger, I. and Ay, C. (2021) Growth Differentiation Factor-15 Predicts Major Adverse Cardiac Events and All-Cause Mortality in Patients with Atrial Fibrillation. European Journal of Internal Medicine, 88, 35-42. [Google Scholar] [CrossRef] [PubMed]
[19] Fox, K.A.A., Lucas, J.E., Pieper, K.S., Bassand, J., Camm, A.J., Fitzmaurice, D.A., et al. (2017) Improved Risk Stratification of Patients with Atrial Fibrillation: An Integrated GARFIELD-AF Tool for the Prediction of Mortality, Stroke and Bleed in Patients with and without Anticoagulation. BMJ Open, 7, e017157. [Google Scholar] [CrossRef] [PubMed]
[20] Bassand, J., Apenteng, P.N., Atar, D., Camm, A.J., Cools, F., Corbalan, R., et al. (2021) GARFIELD-AF: A Worldwide Prospective Registry of Patients with Atrial Fibrillation at Risk of Stroke. Future Cardiology, 17, 19-38. [Google Scholar] [CrossRef] [PubMed]
[21] Apenteng, P.N., Prieto-Merino, D., Hee, S.W., Lobban, T.C., Caleyachetty, R. and Fitzmaurice, D.A. (2023) Optimising Prediction of Mortality, Stroke, and Major Bleeding for Patients with Atrial Fibrillation: Validation of the GARFIELD-AF Tool in UK Primary Care Electronic Records. British Journal of General Practice, 73, e816-e824. [Google Scholar] [CrossRef] [PubMed]
[22] Fox, K.A.A., Virdone, S., Pieper, K.S., Bassand, J., Camm, A.J., Fitzmaurice, D.A., et al. (2022) GARFIELD-AF Risk Score for Mortality, Stroke, and Bleeding within 2 Years in Patients with Atrial Fibrillation. European Heart Journal-Quality of Care and Clinical Outcomes, 8, 214-227. [Google Scholar] [CrossRef] [PubMed]
[23] Krittayaphong, R., Kanjanarutjawiwat, W., Wisaratapong, T. and Lip, G.Y.H. (2023) Improving Risk Prediction for Death, Stroke and Bleeding in Asian Patients with Atrial Fibrillation. European Journal of Clinical Investigation, 53, e13886. [Google Scholar] [CrossRef] [PubMed]
[24] Bucci, T., Shantsila, A., Romiti, G.F., Teo, W., Chao, T., Shimizu, W., et al. (2024) External Validation of COOL-AF Scores in the Asian Pacific Heart Rhythm Society Atrial Fibrillation Registry. JACC: Asia, 4, 59-69. [Google Scholar] [CrossRef] [PubMed]
[25] Yang, C., Peng, C., Huang, L., Chen, F.Y., Kuo, C., Wu, C., et al. (2023) Comparison between Multiple Logistic Regression and Machine Learning Methods in Prediction of Abnormal Thallium Scans in Type 2 Diabetes. World Journal of Clinical Cases, 11, 7951-7964. [Google Scholar] [CrossRef] [PubMed]
[26] Joddrell, M., El-Bouri, W., Harrison, S.L., Huisman, M.V., Lip, G.Y.H. and Zheng, Y. (2024) Machine Learning for Outcome Prediction in Patients with Non-Valvular Atrial Fibrillation from the GLORIA-AF Registry. Scientific Reports, 14, Article No. 27088. [Google Scholar] [CrossRef] [PubMed]
[27] Ali, S., Akhlaq, F., Imran, A.S., Kastrati, Z., Daudpota, S.M. and Moosa, M. (2023) The Enlightening Role of Explainable Artificial Intelligence in Medical & Healthcare Domains: A Systematic Literature Review. Computers in Biology and Medicine, 166, Article ID: 107555. [Google Scholar] [CrossRef] [PubMed]
[28] Lundberg, S. and Lee, S.I. (2017) A Unified Approach to Interpreting Model Predictions. arXiv: 1705.07874.
[29] Ribeiro, M., Singh, S. and Guestrin, C. (2016) “Why Should I Trust You?”: Explaining the Predictions of Any Classifier. Proceedings of the 2016 Conference of the North American Chapter of the Association for Computational Linguistics: Demonstrations, San Diego, June 2016, 97-101. [Google Scholar] [CrossRef
[30] van Maurik, I.S., Doodeman, H.J., Veeger-Nuijens, B.W., Möhringer, R.P.M., Sudiono, D.R., Jongbloed, W., et al. (2024) Targeted Development and Validation of Clinical Prediction Models in Secondary Care Settings: Opportunities and Challenges for Electronic Health Record Data. JMIR Medical Informatics, 12, e57035-e57035. [Google Scholar] [CrossRef] [PubMed]
[31] Baron, J.M., Huang, R., McEvoy, D. and Dighe, A.S. (2021) Use of Machine Learning to Predict Clinical Decision Support Compliance, Reduce Alert Burden, and Evaluate Duplicate Laboratory Test Ordering Alerts. JAMIA Open, 4, ooab006. [Google Scholar] [CrossRef] [PubMed]
[32] Reddy, R.G., Danford, D.A. and Kutty, S. (2025) Silencing the Monitor That Cried Wolf: A Role for Artificial Intelligence. JACC: Advances, 4, Article ID: 101997. [Google Scholar] [CrossRef] [PubMed]